Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Tonix Pharmaceuticals Holding (TNXP) Revenue: 2023-2024

Historic Revenue for Tonix Pharmaceuticals Holding (TNXP) over the last 2 years, with Dec 2024 value amounting to $10.1 million.

  • Tonix Pharmaceuticals Holding's Revenue rose 16.58% to $3.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.3 million, marking a year-over-year decrease of 8.79%. This contributed to the annual value of $10.1 million for FY2024, which is 29.94% up from last year.
  • According to the latest figures from FY2024, Tonix Pharmaceuticals Holding's Revenue is $10.1 million, which was up 29.94% from $7.8 million recorded in FY2023.
  • Tonix Pharmaceuticals Holding's Revenue's 5-year high stood at $10.1 million during FY2024, with a 5-year trough of $7.8 million in FY2023.
  • Moreover, its 2-year median value for Revenue was $8.9 million (2023), whereas its average is $8.9 million.
  • Data for Tonix Pharmaceuticals Holding's Revenue shows a peak YoY increased of 29.94% (in 2024) over the last 5 years.
  • Tonix Pharmaceuticals Holding's Revenue (Yearly) stood at $7.8 million in 2023, then increased by 29.94% to $10.1 million in 2024.